Zavation at NASS 2023

The North American Spine Society (NASS) 2023 conference held in Los Angeles, California, brought together a diverse assembly of medical professionals, including surgeons, medical device manufacturers, and marketers. Among the event’s highlights was an exclusive interview conducted by Doctech.live with Jeff Mathews, a representative from Zavation. This conversation delved into Zavation’s merger with CoreLink and their forward-looking vision for the world of spinal implant technology. In this article, we will delve into the key insights from this enlightening discussion.

Zavation, a medical device company with a mission to lead in spinal solutions, recently merged with CoreLink, another significant player in the field. Jeff Mathews underscored the importance of this merger, explaining, “We’ve united two manufacturing giants, and our aim is to become the most vertically integrated company in the nation.” This strategic merger, intended to streamline operations and broaden their product offerings, positions Zavation to exert a substantial influence in the spinal implant technology domain.

Zavation’s interview at NASS 2023, conducted by Doctech.live, shed light on their ambitious vision for the future of spinal implant technology. Their merger with CoreLink, patient-centric approach, innovative product portfolio, and commitment to education and collaboration position them as a significant player in the medical device industry. As they continue to expand and innovate, Zavation is poised to make a substantial impact on the field of spinal surgery, ultimately enhancing the lives of patients worldwide.